BRAINTEASER app aims to collect the evolution of ALS and MS disease following state of art approach based on the collection of standard questionnaire, physiological monitoring using wearable devices (Garmin devices), symptoms reporting and personalised support according to the type of disease and progress.
The app is part of the EU project called BRAINTEASER (Grant id H2020-101017598) at it will be used to validate the prognostic tools and risk assessment models created in the project.
More information can be found here: Brainteaser